Co-Authors
This is a "connection" page, showing publications co-authored by Keith Terada and Hyeong Jun Ahn.
Connection Strength
1.389
-
Terada KY, Elia J, Kim R, Carney M, Ahn HJ. Abnormal CA-125 levels in menopausal women without ovarian cancer. Gynecol Oncol. 2014 Oct; 135(1):34-7.
Score: 0.499
-
Hernandez-Caballero AI, Vierkoetter KR, Ahn HJ, Shimizu D, Terada K. Novel immunohistochemical markers in the differential diagnosis of endocervical and endometrial adenocarcinoma: The added benefit of CAIX and PAX8. Gynecol Oncol Rep. 2020 Aug; 33:100614.
Score: 0.188
-
Vierkoetter K, Wong J, Ahn HJ, Shimizu D, Kagami L, Terada K. Using gene expression in patients with endometrial intraepithelial neoplasia to assess the risk of cancer. Gynecol Oncol Rep. 2018 May; 24:24-26.
Score: 0.159
-
Terada KY, Ahn HJ, Kessel B. Differences in risk for type 1 and type 2 ovarian cancer in a large cancer screening trial. J Gynecol Oncol. 2016 May; 27(3):e25.
Score: 0.140
-
Lai T, Kessel B, Ahn HJ, Terada KY. Ovarian cancer screening in menopausal females with a family history of breast or ovarian cancer. J Gynecol Oncol. 2016 Jul; 27(4):e41.
Score: 0.140
-
Vierkoetter KR, Kagami LA, Ahn HJ, Shimizu DM, Terada KY. Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions. Int J Gynecol Cancer. 2016 Feb; 26(2):228-32.
Score: 0.138
-
Vierkoetter KR, Ayabe AR, VanDrunen M, Ahn HJ, Shimizu DM, Terada KY. Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary. Gynecol Oncol. 2014 Oct; 135(1):81-4.
Score: 0.124